Last reviewed · How we verify
NCT07512726
DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer
NA trial testing web based supportive care programme in Colorectal Cancer in 24 participants. Completed in 30 January 2026.
3 January 2026
Quick facts
| Lead sponsor | Ilknur Yazicioglu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 24 |
| Start date | 8 August 2025 |
| Primary completion | 3 January 2026 |
| Estimated completion | 30 January 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- web based supportive care programme
Conditions studied
- Colorectal Cancer — all drugs for Colorectal Cancer →
- Colorectal (Colon or Rectal) Cancer — all drugs for Colorectal (Colon or Rectal) Cancer →
Sponsor
Ilknur Yazicioglu
Who can join
18 and older, any sex, with Colorectal Cancer or Colorectal (Colon or Rectal) Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was designed to develop and evaluate the effectiveness of a web-based supportive care program for individuals diagnosed with colorectal cancer undergoing cancer treatment. The program's effectiveness is evaluated based on the symptom burden and quality of life experienced by patients during cancer treatment. This randomized controlled trial was conducted with the participation of patients diagnosed with colorectal cancer receiving treatment at the Outpatient Chemotherapy Unit of Koç University Hospital. Participants were divided into two groups: an intervention group and a control group. Patients in the intervention group were provided with access to the web-based 'Sağlıkta Buluşalım (Meet in Health) Supportive Care Program' for 3 months in addition to routine care, while the control group received standard care. Data collection tools included a Descriptive Information Form, Edmonton Symptom Assessment System (ESAS), Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Website Usability Scale, and a Telephone Follow-up Form. Statistical analyses, including Mann-Whitney U, Pearson Chi-Square, Fisher's Exact, and Friedman tests, were planned to compare symptom levels and quality of life scores within and between groups over time.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07512726
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Cancer
Currently open trials in the same condition.
- NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
- NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07512726 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ilknur Yazicioglu
- Last refreshed: 6 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07512726.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing